The new owner of the New York Mets, Steve Cohen, clearly didn’t want to hear the news that came down on Wednesday, when he took control of the team.
What was the news?
Major League Baseball Commissioner Rob Manfred announced that Mets’ second baseman Robinson Cano will be suspended for the entire 2021 season after he tested positive for the prohibited performance-enhancing drug stanozolol.
To say that it is not good is an understatement.
“We were extremely disappointed to be informed about Robinson’s suspension for violating Major League Baseball’s Joint Drug Prevention and Treatment Program.”Sandy Alderson, NY Mets team president
Cano’s current contract for the next three seasons is $24 million a year.
“We were extremely disappointed to be informed about Robinson’s suspension for violating Major League Baseball’s Joint Drug Prevention and Treatment Program,” Mets’ president Sandy Alderson said in a statement.
The Mets traded for Cano, along with Edwin Diaz, in a deal with Seattle in December 2018 in exchange for Jay Bruce, Jarred Kelenic, Gerson Bautista, Justin Dunn and Anthony Swarzak.
All of this comes as Cano played under a $240 million, 10-year deal he signed with Seattle in 2013.
After struggling throughout his first season with the Mets in 2019, Cano rebounded this year, and batted .316, hit 10 home runs and drove in 30 RBIs in 49 games during the Covid-shortened 2020 campaign.